Literature DB >> 21402675

Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity.

Peng-Cheng Xu1, Jun-Jun Zhang, Min Chen, Ji-Cheng Lv, Gang Liu, Wan-Zhong Zou, Hong Zhang, Ming-Hui Zhao.   

Abstract

BACKGROUND: The pathological characteristics of IgA nephropathy (IgAN) are highly variable. Urinary kidney injury molecule-1 (KIM-1) is a sensitive biomarker for proximal tubule injury. The aim of the study is to investigate the value of KIM-1 as a biomarker for assessing the renal injury in IgAN.
METHODS: The levels of urinary KIM-1 in 202 patients with IgAN, 46 patients with other renal diseases as disease controls and 60 healthy blood donors as normal controls were measured. Correlations with clinical and histopathological features of patients with IgAN were evaluated.
RESULTS: The levels of urinary KIM-1 were significantly higher in patients with IgAN than in normal controls (P < 0.001) and in patients with non-IgAN (P = 0.011). Urinary levels of KIM-1 in IgAN positively correlated with levels of serum creatinine and proteinuria and negatively with creatinine clearance. The more severe the tubulointerstitial injury was, the higher the levels of urinary KIM-1. Patients with severe mesangial proliferation, crescents formation or endocapillary proliferation had higher levels of urinary KIM-1 than those without. The levels of tubular KIM-1 expression in immunohistochemistry closely correlated with the levels of urinary KIM-1 (r = 0.553, P = 0.032). Renal survival was significantly worse in patients with elevated urinary KIM-1 (P = 0.020).
CONCLUSION: Urinary KIM-1 may be a useful biomarker to evaluate kidney injury in IgAN.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21402675     DOI: 10.1093/ndt/gfr023

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  20 in total

1.  Relationship of proximal tubular injury to chronic kidney disease as assessed by urinary kidney injury molecule-1 in five cohort studies.

Authors:  Sushrut S Waikar; Venkata Sabbisetti; Johan Ärnlöv; Axel C Carlsson; Josef Coresh; Harold I Feldman; Meredith C Foster; Gudeta D Fufaa; Johanna Helmersson-Karlqvist; Chi-Yuan Hsu; Paul L Kimmel; Anders Larsson; Yumin Liu; Lars Lind; Kathleen D Liu; Theodore E Mifflin; Robert G Nelson; Ulf Risérus; Ramachandran S Vasan; Dawei Xie; Xiaoming Zhang; Joseph V Bonventre
Journal:  Nephrol Dial Transplant       Date:  2016-06-07       Impact factor: 5.992

2.  Structural equation modeling highlights the potential of Kim-1 as a biomarker for chronic kidney disease.

Authors:  Lesley Gardiner; Adebayo Akintola; Gang Chen; Jeffrey M Catania; Vishal Vaidya; Robert C Burghardt; Joseph V Bonventre; Jerome Trzeciakowski; Alan R Parrish
Journal:  Am J Nephrol       Date:  2012-01-20       Impact factor: 3.754

3.  Effect of Rhizoma Polygoni Cuspidati and Ramulus Cinnamomi compatibility on uric acid metabolism and urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in rats with hyperuricemia.

Authors:  Bin Han; Chun-Xia Zhu; Wan Shi; Hui-Zhu Huang; Xu-Guang Hu; Xiao-Ming Zhou; Ming Lei; Zhong Li
Journal:  Chin J Integr Med       Date:  2017-01-24       Impact factor: 1.978

4.  Urine NGAL and KIM-1 in children and adolescents with hyperuricemia.

Authors:  Justyna Tomczak; Anna Wasilewska; Robert Milewski
Journal:  Pediatr Nephrol       Date:  2013-05-15       Impact factor: 3.714

5.  Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery.

Authors:  Chirag R Parikh; Heather Thiessen-Philbrook; Amit X Garg; Deepak Kadiyala; Michael G Shlipak; Jay L Koyner; Charles L Edelstein; Prasad Devarajan; Uptal D Patel; Michael Zappitelli; Catherine D Krawczeski; Cary S Passik; Steven G Coca
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-18       Impact factor: 8.237

6.  Novel renal biomarkers show that creatine supplementation is safe: a double-blind, placebo-controlled randomized clinical trial.

Authors:  José de Oliveira Vilar Neto; Carlos Alberto da Silva; Gdayllon Cavalcante Meneses; Daniel Vieira Pinto; Luciana Catunda Brito; Said Goncalves da Cruz Fonseca; Renata de Sousa Alves; Alice Maria Costa Martins; Cláudio de Oliveira Assumpção; Elizabeth De Francesco Daher
Journal:  Toxicol Res (Camb)       Date:  2020-05-13       Impact factor: 3.524

7.  KIM-1 expression predicts renal outcomes in IgA nephropathy.

Authors:  Soon Hyo Kwon; Moo Yong Park; Jin Seok Jeon; Hyunjin Noh; Soo Jeong Choi; Jin Kuk Kim; Seung Duk Hwang; So Young Jin; Dong Cheol Han
Journal:  Clin Exp Nephrol       Date:  2012-11-08       Impact factor: 2.801

8.  Dual involvement of growth arrest-specific gene 6 in the early phase of human IgA nephropathy.

Authors:  Kojiro Nagai; Masashi Miyoshi; Takei Kake; Naoshi Fukushima; Motokazu Matsuura; Eriko Shibata; Satoshi Yamada; Kazuhiro Yoshikawa; Hiro-Omi Kanayama; Tomoya Fukawa; Kunihisa Yamaguchi; Hirofumi Izaki; Akira Mima; Naoko Abe; Toshikazu Araoka; Taichi Murakami; Fumi Kishi; Seiji Kishi; Tatsuya Tominaga; Tatsumi Moriya; Hideharu Abe; Toshio Doi
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

9.  Molecular Markers of Tubulointerstitial Fibrosis and Tubular Cell Damage in Patients with Chronic Kidney Disease.

Authors:  Shunsaku Nakagawa; Kumiko Nishihara; Hitomi Miyata; Haruka Shinke; Eri Tomita; Moto Kajiwara; Takeshi Matsubara; Noriyuki Iehara; Yoshinobu Igarashi; Hiroshi Yamada; Atsushi Fukatsu; Motoko Yanagita; Kazuo Matsubara; Satohiro Masuda
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

10.  Beneficial effects of creatine phosphate sodium for the treatment of Henoch-Schönlein purpura in patients with early renal damage detected using urinary kidney injury molecule-1 levels.

Authors:  Jianjiang Zhang; Huiqin Zeng; Na Wang; Xiyan Tian; Wenjie Dou; Peipei Shi
Journal:  Eur J Pediatr       Date:  2015-07-30       Impact factor: 3.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.